The Aureate Tradde IPO is a closed SME Fixed Price offer (Fresh capital only) that opened on 29 May 2026. The Aureate Tradde IPO closed on 2 June 2026, with an issue price of ₹70 per share. The Aureate Tradde IPO has a face value of ₹10 and a lot size of 2,000 shares. The Aureate Tradde IPO is listed on 5 June 2026. The Aureate Tradde IPO allotment was scheduled for 3 June 2026.
On the financial front, the Aureate Tradde IPO reported revenue of ₹103 crore for 31 Dec 2025, compared with ₹177 crore for 31 Mar 2025. The Aureate Tradde IPO PAT was ₹4 crore against ₹3 crore. The Aureate Tradde IPO EBITDA stood at ₹7 crore with a 7.20% margin. The Aureate Tradde IPO net worth as of 31 Dec 2025 was ₹17 crore.
Always verify The Aureate Tradde IPO details and GMP data with the official offer document before investing in the Aureate Tradde IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Dec 2025
31 Mar 2025
31 Mar 2024
Total Assets
99
83
64
Revenue
103
177
172
PAT
4
3
1
EBITDA
7
5
3
Net Worth
17
13
11
Reserves
8
13
10
Total Borrowing
38
32
32
Aureate Tradde IPO Financials FAQs
Revenue of Aureate Tradde (Amount in ₹ Crore) — 31 Dec 2025: 103; 31 Mar 2025: 177; 31 Mar 2024: 172. Profit after tax (PAT) — 31 Dec 2025: 4; 31 Mar 2025: 3; 31 Mar 2024: 1.
EBITDA of Aureate Tradde (Amount in ₹ Crore) — 31 Dec 2025: 7; 31 Mar 2025: 5; 31 Mar 2024: 3. The EBITDA margin is 7.20%.
Total assets — 31 Dec 2025: 99; 31 Mar 2025: 83; 31 Mar 2024: 64. Net worth — 31 Dec 2025: 17; 31 Mar 2025: 13; 31 Mar 2024: 11. Reserves & surplus — 31 Dec 2025: 8; 31 Mar 2025: 13; 31 Mar 2024: 10. (Amount in ₹ Crore)
Total borrowing of Aureate Tradde (Amount in ₹ Crore) — 31 Dec 2025: 38; 31 Mar 2025: 32; 31 Mar 2024: 32. Debt-to-equity ratio: 2.21.
The financials shown for Aureate Tradde IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
